Krystal Biotech, Inc. (KRYS) Profit Breakdown
- 2026-06-30: Reportable $66.08M.
- 2025-06-30: Reportable $46.77M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2016-09-30 to 2026-06-30
- Data captured
Profit by product
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $66.08M |
|---|
| 2025-06-30 | $46.77M |
|---|
Net Income (Loss) Attributable to Parent: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $54.77M |
|---|
| 2025-06-30 | $38.33M |
|---|
Operating income: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $58.42M |
|---|
| 2025-06-30 | $39.40M |
|---|